Sign inJoin waitlistJoin the waitlist

Alison Sehgal

Physician · Upmc

Credentials: · · · ·

History

Upmc
Present

Hematology and Medical Oncology
2010–2013
Internal Medicine
2007–2010
Duke University School of Medicine
2003–2007

Research

Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
The Lancet · 2020 · 2,058 citations
Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium
Journal of Clinical Oncology · 2020 · 691 citations
Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial
The Lancet Oncology · 2022 · 573 citations

Annie Im
19 papers
KD
Kathleen Dorritie
19 papers
AR
Anastasios Raptis
17 papers
MB
Michael Boyiadzis
17 papers
MA
Mounzer Agha
17 papers
JH
Jing-Zhou Hou
16 papers
RF
Rafic Farah
15 papers
Robert Redner
12 papers
SL
Seah Lim
10 papers
Brian Hill
9 papers
Andre Goy
8 papers
Charalambos Andreadis
7 papers

Clinical trials

Phase I Study of Mitoxantrone and Etoposide Combined With Hydroxychloroquine, for Relapsed Acute Myelogenous Leukemia
Principal investigator · Terminated · Phase 1
Alison Sehgal, MD, MS
2016–2017
Study of CTO1681 for the Prevention and Treatment of CRS in Patients Receiving CAR T-Cell Therapy
Site PI · Recruiting · Phase 1, Phase 2
CytoAgents, Inc.
2023–2027
Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)
Site PI · Recruiting · Phase 2
Fred Hutchinson Cancer Center
2019–2029
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Site PI · Recruiting
Center for International Blood and Marrow Transplant Research
2011–2041